We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AHT
7751
CALL
Ashford Hospitality Trust
AHT
$19.8M
-11
Closed -$69K
ALTO icon
7752
CALL
Alto Ingredients
ALTO
$315M
-12,300
Closed -$68K
OSG
7753
CALL
Octave Specialty Group
OSG
$210M
-11,200
Closed -$193K
AMRN
7754
PUT
Amarin Corp
AMRN
$297M
-535
Closed -$37K
AMX icon
7755
America Movil
AMX
$69.7B
-13,855
Closed -$242K
ANGO icon
7756
PUT
AngioDynamics
ANGO
$647M
-11,100
Closed -$190K
ANIP icon
7757
CALL
ANI Pharmaceuticals
ANIP
$1.72B
-6,100
Closed -$320K
AORT icon
7758
CALL
Artivion
AORT
$1.39B
-9,500
Closed -$216K
APAM icon
7759
Artisan Partners
APAM
$2.97B
-44,322
Closed -$1.64M
APO icon
7760
Apollo Global Management
APO
$81.9B
-7,774
Closed -$244K
ARCB icon
7761
ArcBest
ARCB
$3.14B
-28,989
Closed -$989K
ARCO icon
7762
Arcos Dorados Holdings
ARCO
$1.66B
-19,650
Closed -$192K
AROW icon
7763
Arrow Financial
AROW
$723M
-11,642
Closed -$335K
ASIX icon
7764
CALL
AdvanSix
ASIX
$427M
-5,600
Closed -$223K
ASND icon
7765
Ascendis Pharma A/S
ASND
$16.8B
-10,273
Closed -$372K
ASPS icon
7766
PUT
Altisource Portfolio Solutions
ASPS
$64.5M
-3,225
Closed -$667K
ATHE
7767
Alterity Therapeutics
ATHE
$89M
-1,400
Closed -$39K
ATKR icon
7768
Atkore
ATKR
$3.17B
-164,586
Closed -$3.21M
ATNM icon
7769
CALL
Actinium Pharmaceuticals
ATNM
$30.2M
-970
Closed -$17K
ATNM icon
7770
Actinium Pharmaceuticals
ATNM
$30.2M
-1,952
Closed -$34K
ATR icon
7771
CALL
AptarGroup
ATR
$8.43B
-2,600
Closed -$224K
AVA icon
7772
PUT
Avista
AVA
$3.23B
-5,600
Closed -$290K
AVK
7773
Advent Convertible and Income Fund
AVK
$577M
-11,601
Closed -$183K
AWP
7774
abrdn Global Premier Properties Fund
AWP
$362M
-7,765
Closed -$154K
AWRE icon
7775
Aware
AWRE
$26M
-35,114
Closed -$163K

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.